Nutritional, Metabolic, Endocrine
Conditions
Interventions
Sponsors
Ifeoma Christiana Afiaenyi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Type 2 diabetics aged 40 years and above. Type 2 diabetics with no obvious complications such as foot ulcer, blindness and stroke. Type 2 diabetics who were neither pregnant nor breastfeeding. Type 2 diabetics who were not obese. Type 2 diabetics who consented to partake in the study.
Exclusion criteria
Exclusion criteria: Type 2 diabetics who were below 40 years of age. Type 2 diabetes with such complications such as foot ulcer, blindness and stroke. Type 2 diabetics who were either pregnant or breastfeeding. Type 2 diabetics who were obese. Type 2 diabetics who did not give their consent to partake in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile: There was a non-significant (p > 0.05) reduction in the mean total cholesterol level of the subjects in groups 1, 2 and 3. Group 2 and 4 had a non-significant (p > 0.05) increase in their mean serum triglyceride from 63.33 mg/dl to 109.00 mg/dl in group 2 and from 107.00 mg/dl to 112.5 mg/dl in group 4. There was a significant (p 0.05) reduction in the mean packed cell volume of the subjects in groups 1, 2 and 3 after the feeding trial. Only the group 4 subjects had a significant (p 0.05) decrease in the mean fasting blood glucose levels of the subjects in group 1 (from 163.67 mg/dl before the feeding to 161.17 mg/dl after the feeding trial). Subjects in group 2 had a non-significant (p > 0.05) increase in their fasting blood glucose level from 146.00 mg/dl before the feeding to 158.00 mg/dl after the feeding. There was a reduction in the fasting blood glucose level of the subjects in group 3 (from 228.33 mg/dl to 225.00 mg/dl); however, the decrease was not significant (p > 0.05). Subjects in group 4 had a non-significant (p > 0.05) increase in their fasting blood glucose levels from 244.00 mg/dl to 265.17 mg/dl before and after the feeding trial respectively.;Blood pressure. Group 3 subjects had a significant (p 0.05) reduction in the diastolic blood pressure of the subjects in groups 2, 3 and 4 from 76.33 mmHg, 78.33 mmHg and 84.00 mmHg before the feeding trial to 71.33 mmHg, 72.00 mmHg and 77.00 mmHg after the feeding trial respectively. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometric measurements. There was a significant (p 0.05) decrease in their mean BMI from 24.45 kg/m2 before the feeding to 24.08 kg/m2 after the feeding. There was a non-significant (p > 0.05) decrease in the mean waist circumference of subjects in groups 2 and 3 from 87.50 cm and 92.17 cm before the feeding to 87.33 cm and 91.17 cm after the feeding trial respectively. Groups 2, 3 and 4 had a non-significant (p > 0.05) decrease in their mean waist hip ratio from 1.02 to 1.01, 1.01 to 1.00 and 1.03 to 1.02 before and after the feeding trial respectively. | — |
Countries
Nigeria
Contacts
Public ContactElizabeth Ngwu
Professor. Universoty of Nigeria Nsukka.
Outcome results
None listed